NCT 06756932 Brief Summary The purpose of this study is to assess…
Read more arrow_forwardNCT 04862663 Brief Summary A Phase Ib/III Open-label, Randomised Study of Capivasertib…
Read more arrow_forwardNCT 05523947 Brief Summary This first-in-human study will be counducted to evaluate…
Read more arrow_forwardNCT 05868174 Brief Summary This is an open label, single-arm, multicentre dose…
Read more arrow_forwardNCT 05756907 Brief Summary This is a Phase 1b/2a, open-label, adaptive-design…
Read more arrow_forwardNCT 05598151 Brief Summary This is a Phase1 study to assess the…
Read more arrow_forwardNCT 06923761 Brief Summary This is a Phase I/II, open-label, first-in human…
Read more arrow_forwardNCT 04739670 Brief Summary The study hypothesise that the combination of carboplatin,…
Read more arrow_forwardNCT 05696626 Brief Summary The goal of this clinical trial is to…
Read more arrow_forwardNCT 05607498 Brief Summary For solid tumors and lymphoma, respectively: This study…
Read more arrow_forward